Clinical Trial Update: Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ONO-2952 for pain perception in female subjects with diarrhea-predominant irritable bowel syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• ONO-2952

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Irritable Bowel Syndrome (IBS) | Phase 2 | Status: TERMINATED